Pezzoli Lorenzo, Pineda Silvia, Halkyer Percy, Crespo Gladys, Andrews Nick, Ronveaux Olivier
European Programme for Intervention Epidemiology Training, European Centre for Disease Control, Stockholm, Sweden.
Trop Med Int Health. 2009 Mar;14(3):355-61. doi: 10.1111/j.1365-3156.2009.02231.x. Epub 2009 Jan 28.
To estimate the yellow fever (YF) vaccine coverage for the endemic and non-endemic areas of Bolivia and to determine whether selected districts had acceptable levels of coverage (>70%).
We conducted two surveys of 600 individuals (25 x 12 clusters) to estimate coverage in the endemic and non-endemic areas. We assessed 11 districts using lot quality assurance sampling (LQAS). The lot (district) sample was 35 individuals with six as decision value (alpha error 6% if true coverage 70%; beta error 6% if true coverage 90%). To increase feasibility, we divided the lots into five clusters of seven individuals; to investigate the effect of clustering, we calculated alpha and beta by conducting simulations where each cluster's true coverage was sampled from a normal distribution with a mean of 70% or 90% and standard deviations of 5% or 10%.
Estimated coverage was 84.3% (95% CI: 78.9-89.7) in endemic areas, 86.8% (82.5-91.0) in non-endemic and 86.0% (82.8-89.1) nationally. LQAS showed that four lots had unacceptable coverage levels. In six lots, results were inconsistent with the estimated administrative coverage. The simulations suggested that the effect of clustering the lots is unlikely to have significantly increased the risk of making incorrect accept/reject decisions.
Estimated YF coverage was high. Discrepancies between administrative coverage and LQAS results may be due to incorrect population data. Even allowing for clustering in LQAS, the statistical errors would remain low. Catch-up campaigns are recommended in districts with unacceptable coverage.
评估玻利维亚流行地区和非流行地区的黄热病(YF)疫苗接种覆盖率,并确定选定地区的覆盖率是否达到可接受水平(>70%)。
我们对600人(25个群,每个群12人)进行了两次调查,以评估流行地区和非流行地区的疫苗接种覆盖率。我们使用批质量保证抽样法(LQAS)对11个地区进行了评估。每个批次(地区)的样本量为35人,判定值为6人(如果实际覆盖率为70%,α误差为6%;如果实际覆盖率为90%,β误差为6%)。为提高可行性,我们将每个批次分为5个群,每个群7人;为研究聚类的影响,我们通过模拟计算α和β值,其中每个群的实际覆盖率从均值为70%或90%、标准差为5%或10%的正态分布中抽样。
流行地区的估计覆盖率为84.3%(95%置信区间:78.9 - 89.7),非流行地区为86.8%(82.5 - 91.0),全国为86.0%(82.8 - 89.1)。LQAS显示,有4个批次的覆盖率未达到可接受水平。在6个批次中,结果与估计的行政覆盖率不一致。模拟结果表明,将批次聚类的影响不太可能显著增加做出错误接受/拒绝决定的风险。
黄热病疫苗的估计接种覆盖率较高。行政覆盖率与LQAS结果之间的差异可能是由于人口数据不准确。即使在LQAS中考虑聚类因素,统计误差仍然较低。建议在覆盖率未达可接受水平的地区开展补种活动。